CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) of $13.90 million for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Income Statement › Other Income
us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, plan assets, foreign currency translation gain (loss) for fiscal 2025 was $13.90M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, plan assets, foreign currency translation gain (loss) for fiscal 2024 was -$2.69M, a 127.25% decline from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, plan assets, foreign currency translation gain (loss) for fiscal 2023 was $9.85M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, plan assets, foreign currency translation gain (loss) for fiscal 2022 was -$23.49M.
| Period end | Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|
| 2025-12-27 | $13.90M 10-K · filed 2026-02-18 |
| 2024-12-28 | -$2.69M 10-K · filed 2026-02-18 |
| 2023-12-30 | $9.85M 10-K · filed 2025-02-19 |
| 2022-12-31 | -$23.49M 10-K · filed 2024-02-14 |
| 2021-12-25 | -$929.00K 10-K · filed 2023-02-22 |
| 2020-12-26 | $8.63M 10-K · filed 2022-02-16 |
| 2019-12-28 | $7.11M 10-K · filed 2021-02-17 |
| 2018-12-29 | -$13.29M 10-K · filed 2020-02-11 |
| 2017-12-30 | $19.06M 10-K · filed 2019-02-13 |
| 2016-12-31 | -$33.54M 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |